Form 4 for GALT GALECTIN THERAPEUTICS INC
Accepted 2026-08-04 07:52:26 ET · period of report 2026-07-31 · accession 0001133416-26-000065 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2026-08-04 07:52 | 2026-07-31 | GALT | Uihlein Richard E | Dir, 10% | M - OptEx | $3.08 | +34.38M | 44.71M | +333% | +$105.81M |
| DMI | 2026-08-04 07:52 | 2026-07-31 | GALT | Uihlein Richard E | Dir, 10% | M - OptEx | — | 0 | 0 | New | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-07-31 | M | A | 31,825,235 | $3.00 | 42,162,911 | I Richard E. Uihlein Stock Trust | — | — | |
| 2 | Common | Common Stock | 2026-07-31 | M | A | 2,550,932 | $4.05 | 44,713,843 | I Richard E. Uihlein Stock Trust | — | — | |
| 3 | Derivative | Line of Credit Convertible Notes | 2026-07-31 | M | D | — | $95,475,705.00 | 0 | I Richard E. Uihlein Stock Trust | $3.00 · 2022-12-19 to 2027-06-30 | 31,825,235 Common Stock | (F1) Consists of $91,000,000 in principal and $14,475,705 in accrued interest. (F1) Consists of $91,000,000 in principal and $14,475,705 in accrued interest. (F3) The Line of Credit Convertible Notes are exercisable upon issuance when the issuer draws on the Line of Credit. Notes were issued on December 19, 2022; March 31, 2023; June 30, 2023; December 29, 2023; March 29, 2024; June 28, 2024; September30, 2024; April 30, 2025; June 30, 2025 and December 31, 2025. There was no expiration date; however, the maturity date of all Line of Credit Convertible Notes was June 30, 2027. (F3) The Line of Credit Convertible Notes are exercisable upon issuance when the issuer draws on the Line of Credit. Notes were issued on December 19, 2022; March 31, 2023; June 30, 2023; December 29, 2023; March 29, 2024; June 28, 2024; September30, 2024; April 30, 2025; June 30, 2025 and December 31, 2025. There was no expiration date; however, the maturity date of all Line of Credit Convertible Notes was June 30, 2027. |
| 4 | Derivative | Line of Credit Convertible Notes | 2026-07-31 | M | D | — | $10,331,275.00 | 0 | I Richard E. Uihlein Stock Trust | $4.05 · 2025-12-31 to 2027-06-30 | 2,550,932 Common Stock | (F2) Consists of $10,000,000 of principal and $331,275 of accrued interest. (F2) Consists of $10,000,000 of principal and $331,275 of accrued interest. (F3) The Line of Credit Convertible Notes are exercisable upon issuance when the issuer draws on the Line of Credit. Notes were issued on December 19, 2022; March 31, 2023; June 30, 2023; December 29, 2023; March 29, 2024; June 28, 2024; September30, 2024; April 30, 2025; June 30, 2025 and December 31, 2025. There was no expiration date; however, the maturity date of all Line of Credit Convertible Notes was June 30, 2027. (F3) The Line of Credit Convertible Notes are exercisable upon issuance when the issuer draws on the Line of Credit. Notes were issued on December 19, 2022; March 31, 2023; June 30, 2023; December 29, 2023; March 29, 2024; June 28, 2024; September30, 2024; April 30, 2025; June 30, 2025 and December 31, 2025. There was no expiration date; however, the maturity date of all Line of Credit Convertible Notes was June 30, 2027. |